Patents by Inventor Erin N. Reisfeld

Erin N. Reisfeld has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240090815
    Abstract: A method comprises identifying P-waves within a cardiac signal stored by a medical device for a cardiac episode detected by the medical device, and calculating a gain factor for display of the cardiac signal based on the identified P-waves.
    Type: Application
    Filed: November 27, 2023
    Publication date: March 21, 2024
    Inventors: Erin N. Reisfeld, Joseph C. Green, Ryan D. Wyszynski
  • Patent number: 11826149
    Abstract: A method comprises identifying P-waves within a cardiac signal stored by a medical device for a cardiac episode detected by the medical device, and calculating a gain factor for display of the cardiac signal based on the identified P-waves.
    Type: Grant
    Filed: November 2, 2020
    Date of Patent: November 28, 2023
    Assignee: Medtronic, Inc.
    Inventors: Erin N. Reisfeld, Joseph C. Green, Ryan D. Wyszynski
  • Patent number: 11806154
    Abstract: A system and method for detecting and verifying bradycardia/asystole episodes includes sensing an electrogram (EGM) signal. The EGM signal is compared to a primary threshold to sense events in the EGM signal, and at least one of a bradycardia or an asystole is detected based on the comparison. In response to detecting at least one of a bradycardia or an asystole, the EGM signal is compared to a secondary threshold to sense events under-sensed by the primary threshold. The validity of the bradycardia or the asystole is determined based on the detected under-sensed events.
    Type: Grant
    Filed: November 15, 2021
    Date of Patent: November 7, 2023
    Assignee: Medtronic, Inc.
    Inventors: Shantanu Sarkar, Michael L Hudziak, Jerry D. Reiland, Erin N. Reisfeld
  • Publication number: 20230117943
    Abstract: A system for minimizing misalignment notifications for a TETS having an implantable blood pump, an external controller having a power source and a processing circuitry, a transmission coil in communication with the external controller, a receiving coil configured for transcutaneous inductive communication with the transmission coil, and an implantable controller in communication with the receiving coil and the implantable blood pump. The implantable controller having a power source configured to receive power from the receiving coil. The processing circuitry may be configured to: operate in a first mode where an alert is generated when a power efficiency transfer between the transmission coil and the receiving coil is below a first predetermined threshold; and operate in a second mode where the alert is only generated when the power remaining in the power source for the implantable controller is below a first predetermined power source threshold.
    Type: Application
    Filed: December 15, 2022
    Publication date: April 20, 2023
    Inventors: Eric A. Schilling, Brian D. Kuhnley, Erin N. Reisfeld, Stephen M. Nelson, Nathanael O. Mason
  • Publication number: 20230070267
    Abstract: A controller implantable within the body of a patient as part of a left ventricular assist device (LVAD) system and a method therefore are provided. According to one aspect, the controller includes processing circuitry configured to receive inputs from at least one of: at least one internal component of the LVAD system, at least one external component of the LVAD system, and at least one clinician's device, and determine a charging rate for charging a battery of the LVAD system internal to the patient based on at least one of the received inputs.
    Type: Application
    Filed: November 14, 2022
    Publication date: March 9, 2023
    Inventors: Eric A. Schilling, Erin N. Reisfeld, Thomas W. Radtke, Brian D. Kuhnley, David I. Siegried
  • Publication number: 20230064020
    Abstract: This disclosure describes systems, devices and techniques for improving the longevity of battery life in a device. An example first device includes communication circuitry configured to communicate with a second device and processing circuitry configured to determine an expected amount of data to be transmitted by the second device to the first device. The processing circuitry is configured to determine that the expected amount of data to be transmitted by the second device to the first device is greater than or equal to a predetermined data threshold and based on the expected amount of data to be transmitted being greater than or equal to the predetermined data threshold, determine that a predetermined restriction is met. The processing circuitry is configured to, based on the predetermined restriction being met, control the communication circuitry to transmit an instruction to the second device.
    Type: Application
    Filed: August 23, 2022
    Publication date: March 2, 2023
    Inventors: Matthew J. Hoffman, Ryan D. Wyszynski, Erin N. Reisfeld, Bo Zhang, Christopher D. Koch
  • Patent number: 11547847
    Abstract: A system for minimizing misalignment notifications for a TETS having an implantable blood pump, an external controller having a power source and a processing circuitry, a transmission coil in communication with the external controller, a receiving coil configured for transcutaneous inductive communication with the transmission coil, and an implantable controller in communication with the receiving coil and the implantable blood pump. The implantable controller having a power source configured to receive power from the receiving coil. The processing circuitry may be configured to: operate in a first mode where an alert is generated when a power efficiency transfer between the transmission coil and the receiving coil is below a first predetermined threshold; and operate in a second mode where the alert is only generated when the power remaining in the power source for the implantable controller is below a first predetermined power source threshold.
    Type: Grant
    Filed: March 12, 2020
    Date of Patent: January 10, 2023
    Assignee: MEDTRONIC, INC.
    Inventors: Eric A. Schilling, Brian D. Kuhnley, Erin N. Reisfeld, Stephen M. Nelson, Nathanael O. Mason
  • Patent number: 11497905
    Abstract: A controller implantable within the body of a patient as part of a left ventricular assist device (LVAD) system and a method therefore are provided. According to one aspect, the controller includes processing circuitry configured to receive inputs from at least one of: at least one internal component of the LVAD system, at least one external component of the LVAD system, and at least one clinician's device, and determine a charging rate for charging a battery of the LVAD system internal to the patient based on at least one of the received inputs.
    Type: Grant
    Filed: May 13, 2020
    Date of Patent: November 15, 2022
    Assignee: Medtronic, Inc.
    Inventors: Eric A. Schilling, Erin N. Reisfeld, Thomas W. Radtke, Brian D. Kuhnley, David Siegfried
  • Publication number: 20220133168
    Abstract: A method comprises identifying P-waves within a cardiac signal stored by a medical device for a cardiac episode detected by the medical device, and calculating a gain factor for display of the cardiac signal based on the identified P-waves.
    Type: Application
    Filed: November 2, 2020
    Publication date: May 5, 2022
    Inventors: Erin N. Reisfeld, Joseph C. Green, Ryan D. Wyszynski
  • Publication number: 20220071545
    Abstract: A system and method for detecting and verifying bradycardia/asystole episodes includes sensing an electrogram (EGM) signal. The EGM signal is compared to a primary threshold to sense events in the EGM signal, and at least one of a bradycardia or an asystole is detected based on the comparison. In response to detecting at least one of a bradycardia or an asystole, the EGM signal is compared to a secondary threshold to sense events under-sensed by the primary threshold. The validity of the bradycardia or the asystole is determined based on the detected under-sensed events.
    Type: Application
    Filed: November 15, 2021
    Publication date: March 10, 2022
    Inventors: Shantanu Sarkar, Michael L. Hudziak, Jerry D. Reiland, Erin N. Reisfeld
  • Publication number: 20220026391
    Abstract: A method of estimating a depth of an implanted receiving coil of a transcutaneous energy transfer system (TETS) includes aligning the implanted receiving coil with an external transmission coil. A coupling coefficient between the implanted receiving coil and the external transmission coil is estimated based on a first transfer function and operating conditions. The depth of the implanted receiving coil is estimated from the estimated coupling coefficient based on a second transfer function.
    Type: Application
    Filed: July 24, 2020
    Publication date: January 27, 2022
    Inventors: Eric A. SCHILLING, Erin N. REISFELD, David J. PEICHEL
  • Publication number: 20210353838
    Abstract: A controller implantable within the body of a patient as part of a left ventricular assist device (LVAD) system and a method therefore are provided. According to one aspect, the controller includes processing circuitry configured to receive inputs from at least one of: at least one internal component of the LVAD system, at least one external component of the LVAD system, and at least one clinician's device, and determine a charging rate for charging a battery of the LVAD system internal to the patient based on at least one of the received inputs.
    Type: Application
    Filed: May 13, 2020
    Publication date: November 18, 2021
    Inventors: Eric A. Schilling, Erin N. Reisfeld, Thomas W. Radtke, Brian D. Kuhnley, David Siegfried
  • Patent number: 11172863
    Abstract: A system and method for detecting and verifying bradycardia/asystole episodes includes sensing an electrogram (EGM) signal. The EGM signal is compared to a primary threshold to sense events in the EGM signal, and at least one of a bradycardia or an asystole is detected based on the comparison. In response to detecting at least one of a bradycardia or an asystole, the EGM signal is compared to a secondary threshold to sense events under-sensed by the primary threshold. The validity of the bradycardia or the asystole is determined based on the detected under-sensed events.
    Type: Grant
    Filed: May 18, 2021
    Date of Patent: November 16, 2021
    Assignee: Medtronic, Inc.
    Inventors: Shantanu Sarkar, Michael L. Hudziak, Jerry D. Reiland, Erin N. Reisfeld
  • Publication number: 20210283321
    Abstract: A system for minimizing misalignment notifications for a TETS having an implantable blood pump, an external controller having a power source and a processing circuitry, a transmission coil in communication with the external controller, a receiving coil configured for transcutaneous inductive communication with the transmission coil, and an implantable controller in communication with the receiving coil and the implantable blood pump. The implantable controller having a power source configured to receive power from the receiving coil. The processing circuitry may be configured to: operate in a first mode where an alert is generated when a power efficiency transfer between the transmission coil and the receiving coil is below a first predetermined threshold; and operate in a second mode where the alert is only generated when the power remaining in the power source for the implantable controller is below a first predetermined power source threshold.
    Type: Application
    Filed: March 12, 2020
    Publication date: September 16, 2021
    Inventors: Eric A. SCHILLING, Brian D. KUHNLEY, Erin N. REISFELD, Stephen M. NELSON, Nathanael O. MASON
  • Publication number: 20210267528
    Abstract: A system and method for detecting and verifying bradycardia/asystole episodes includes sensing an electrogram (EGM) signal. The EGM signal is compared to a primary threshold to sense events in the EGM signal, and at least one of a bradycardia or an asystole is detected based on the comparison. In response to detecting at least one of a bradycardia or an asystole, the EGM signal is compared to a secondary threshold to sense events under-sensed by the primary threshold. The validity of the bradycardia or the asystole is determined based on the detected under-sensed events.
    Type: Application
    Filed: May 18, 2021
    Publication date: September 2, 2021
    Inventors: Shantanu Sarkar, Michael L. Hudziak, Jerry D. Reiland, Erin N. Reisfeld